Status:
COMPLETED
The Development of Pancreatic Injury in the Course of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Lead Sponsor:
Uşak University
Conditions:
Pancreatitis
Eligibility:
All Genders
18+ years
Brief Summary
Although COVID-19 disease due to Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) affects the respiratory tract, heart and coagulation system, symptoms of gastrointestinal system involveme...
Eligibility Criteria
Inclusion
- Patients with amylase and lipase levels measured during covid-19 disease with or without pneumonia
Exclusion
- Patients with pregnancy
- Patients whose amylase and lipase levels were not measured during covid 19 disease
- Patients with known solid organ malignacy
- Patients with known hematologic malignacy
Key Trial Info
Start Date :
March 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 12 2020
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04433754
Start Date
March 1 2020
End Date
June 12 2020
Last Update
June 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Usak University Training and Research Hospital
Uşak, Turkey (Türkiye), 64200